GB9122988D0
(en)
*
|
1991-10-30 |
1991-12-18 |
Ici Plc |
Heterocyclic compounds
|
GB9127279D0
(en)
*
|
1991-12-23 |
1992-02-19 |
Ici Plc |
Heterocyclic derivatives
|
GB9201749D0
(en)
*
|
1992-01-28 |
1992-03-11 |
Smithkline Beecham Plc |
Medicaments
|
US5726306A
(en)
*
|
1992-04-20 |
1998-03-10 |
Takeda Chemical Industries, Ltd. |
4,1-benzoxazepin derivatives and their use
|
WO1993021184A1
(en)
*
|
1992-04-10 |
1993-10-28 |
Zeneca Limited |
Biphenylylquinuclidine derivatives as squalene synthase inhibitors
|
GB9207961D0
(en)
*
|
1992-04-10 |
1992-05-27 |
Ici Plc |
Heterocyclic derivatives
|
EP0567026B1
(en)
*
|
1992-04-20 |
2003-03-26 |
Takeda Chemical Industries, Ltd. |
4,1-Benzoxazepin derivatives as squalene synthase inhibitors and their use in the treatment of hypercholesteremia and as fungicides
|
GB9211796D0
(en)
*
|
1992-06-04 |
1992-07-15 |
Ici Plc |
Heterocyclic derivatives
|
GB9216721D0
(en)
*
|
1992-08-06 |
1992-09-23 |
Ici Plc |
Therapeutic heterocyclic derivatives
|
GB9218334D0
(en)
*
|
1992-08-28 |
1992-10-14 |
Ici Plc |
Heterocyclic compounds
|
GB9226577D0
(en)
*
|
1992-12-21 |
1993-02-17 |
Ici Plc |
Heterocyclic derivatives
|
GB9226573D0
(en)
*
|
1992-12-21 |
1993-02-17 |
Ici Plc |
Heterocyclic compounds
|
JPH08504801A
(ja)
*
|
1992-12-21 |
1996-05-28 |
ゼネカ・リミテッド |
スクアレンシンターゼ阻害剤としてのキヌクリジン誘導体
|
US5451596A
(en)
*
|
1992-12-29 |
1995-09-19 |
Rhone Poulenc Rorer Pharmaceuticals Inc. |
Cycloalkyl amine bis-aryl squalene synthase inhibitors
|
CA2115183A1
(en)
*
|
1993-02-12 |
1994-08-13 |
Takashi Nomoto |
Substituted amic acid derivatives
|
IL109451A0
(en)
*
|
1993-04-29 |
1994-07-31 |
Zeneca Ltd |
Heterocyclic derivatives
|
AU678503B2
(en)
*
|
1993-09-24 |
1997-05-29 |
Takeda Chemical Industries Ltd. |
Condensed heterocyclic compounds and their use as squalene synthetase inhibitors
|
GB9412145D0
(en)
*
|
1994-06-17 |
1994-08-10 |
Zeneca Ltd |
Heterocycles
|
US5556990A
(en)
*
|
1994-12-16 |
1996-09-17 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Polyarylcarbamoylaza- and -carbamoylalkanedioic acids
|
US6297198B1
(en)
|
1996-05-14 |
2001-10-02 |
Syngenta Participations Ag |
Isoxazole derivatives and their use as herbicides
|
SE9902987D0
(sv)
|
1999-08-24 |
1999-08-24 |
Astra Pharma Prod |
Novel compounds
|
US6599917B1
(en)
|
1999-09-28 |
2003-07-29 |
Eisai Co., Ltd. |
Quinuclidine compounds and drugs containing the same as the active ingredient
|
US6486172B2
(en)
|
2000-08-18 |
2002-11-26 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted aryl compounds for treatment of disease
|
US6492385B2
(en)
|
2000-08-18 |
2002-12-10 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease
|
WO2002016358A2
(en)
|
2000-08-18 |
2002-02-28 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
|
WO2002015662A2
(en)
|
2000-08-21 |
2002-02-28 |
Pharmacia & Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
|
AU2001282875A1
(en)
|
2000-08-21 |
2002-03-04 |
Pharmacia And Upjohn Company |
Quinuclidine-substituted heteroaryl moieties for treatment of disease
|
GB0104050D0
(en)
|
2001-02-19 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
GB0107228D0
(en)
|
2001-03-22 |
2001-05-16 |
Astrazeneca Ab |
Chemical compounds
|
WO2002076973A1
(fr)
*
|
2001-03-27 |
2002-10-03 |
Eisai Co., Ltd. |
Derive d'amine cyclique a substitution n-aryle et medicament contenant ledit derive en tant que principe actif
|
PE20021019A1
(es)
|
2001-04-19 |
2002-11-13 |
Upjohn Co |
Grupos azabiciclicos sustituidos
|
CA2458375A1
(en)
|
2001-08-24 |
2003-03-06 |
Pharmacia & Upjohn Company |
Substituted-heteroaryl-7-aza¬2.2.1|bicycloheptanes for the treatment of disease
|
JP2005511613A
(ja)
|
2001-11-08 |
2005-04-28 |
ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー |
疾患治療用アザビシクロ置換ヘテロアリール化合物
|
SE0103818D0
(sv)
|
2001-11-15 |
2001-11-15 |
Astrazeneca Ab |
Chemical compounds
|
JP2005522456A
(ja)
|
2002-02-15 |
2005-07-28 |
ファルマシア・アンド・アップジョン・カンパニー・エルエルシー |
Cns関連障害治療のためのアザビシクロ置換ベンゾイルアミドおよびチオアミド
|
US7176198B2
(en)
|
2002-08-01 |
2007-02-13 |
Pfizer Inc. |
1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease
|
GB0220581D0
(en)
|
2002-09-04 |
2002-10-09 |
Novartis Ag |
Organic Compound
|
SE0301369D0
(sv)
|
2003-05-09 |
2003-05-09 |
Astrazeneca Ab |
Chemical compounds
|
DE10334724A1
(de)
*
|
2003-07-30 |
2005-02-24 |
Bayer Healthcare Ag |
N-Biarylamide
|
US7655657B2
(en)
|
2003-12-22 |
2010-02-02 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
US20050245531A1
(en)
*
|
2003-12-22 |
2005-11-03 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
US7160876B2
(en)
|
2003-12-22 |
2007-01-09 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
PE20060437A1
(es)
|
2004-06-18 |
2006-06-08 |
Novartis Ag |
COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
|
GB0415746D0
(en)
|
2004-07-14 |
2004-08-18 |
Novartis Ag |
Organic compounds
|
US7781478B2
(en)
|
2004-07-14 |
2010-08-24 |
Ptc Therapeutics, Inc. |
Methods for treating hepatitis C
|
AU2004325725A1
(en)
*
|
2004-12-10 |
2006-06-22 |
Abbott Laboratories |
Fused bicycloheterocycle substituted quinuclidine derivatives
|
GB0611907D0
(en)
|
2006-06-15 |
2006-07-26 |
Glaxo Group Ltd |
Compounds
|
CA2597616A1
(en)
|
2005-02-17 |
2006-08-24 |
Wyeth |
Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives
|
GB0521508D0
(en)
|
2005-10-21 |
2005-11-30 |
Novartis Ag |
Organic compounds
|
GB0525672D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
GB0525673D0
(en)
|
2005-12-16 |
2006-01-25 |
Novartis Ag |
Organic compounds
|
US8314119B2
(en)
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
MX2013003344A
(es)
|
2010-09-23 |
2013-06-28 |
Abbvie Inc |
Monohidrato de un derivado de azaadamantano.
|
CN107001267A
(zh)
*
|
2014-08-08 |
2017-08-01 |
马合伙人株式会社 |
稠合杂环化合物
|
EA034994B1
(ru)
*
|
2016-02-15 |
2020-04-15 |
Санофи |
6,7-дигидро-5h-бензо[7]аннуленовые производные в качестве модуляторов эстрогеновых рецепторов
|
CA3043646A1
(en)
|
2016-11-17 |
2018-05-24 |
Sanofi |
Novel substituted n-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof
|
EP3434272A1
(en)
|
2017-07-25 |
2019-01-30 |
Sanofi |
Combination comprising palbociclib and 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic acid
|
IL281191B
(en)
|
2018-09-07 |
2022-07-01 |
Sanofi Sa |
Salts of methyl 6-(4,2-dichlorophenyl)-5-[4-[(s3)-1-(3-fluoropropyl)pyrrolidine-3-yl]oxyphenyl]-9,8-dihydro-h7-benzo[7 ]anolane-2-carboxylate and processes for their preparation
|